Deutsche Bank Ag\ Outlook Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.2 - $1.78 $10,645 - $94,740	-53,225 Reduced 83.8%	10,287 $2,000
Q2 2023 Aug 14, 2023	SELL	$1.02 - $1.89 $36,460 - $67,559	-35,746 Reduced 36.01%	63,512 $110,000
Q1 2023 May 15, 2023	BUY	$1.0 - $1.35 $48,100 - $64,935	48,100 Added 94.02%	99,258 $108,000
Q4 2022 Feb 13, 2023	BUY	$0.87 - $1.33 $688 - $1,052	791 Added 1.57%	51,158 $55,000
Q3 2022 Nov 14, 2022	SELL	$1.02 - $1.26 $8,065 - $9,962	-7,907 Reduced 13.57%	50,367 $61,000
Q2 2022 Aug 11, 2022	BUY	$0.91 - $2.01 $5,976 - $13,201	6,568 Added 12.7%	58,274 $60,000
Q1 2022 May 13, 2022	SELL	$1.22 - $2.03 $12,307 - $20,478	-10,088 Reduced 16.33%	51,706 $92,000
Q4 2021 Feb 11, 2022	BUY	$1.27 - $2.23 $13,417 - $23,559	10,565 Added 20.62%	61,794 $84,000
Q3 2021 Nov 04, 2021	SELL	$2.12 - $2.76 $1,617 - $2,105	-763 Reduced 1.47%	51,229 $111,000
Q2 2021 Aug 11, 2021	BUY	$1.78 - $2.76 $92,545 - $143,497	51,992 New	51,992 $129,000
Q1 2020 May 14, 2020	SELL	$0.51 - $1.08 $13,108 - $27,759	-25,703 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.53 - $1.59 $13,622 - $40,867	25,703 New	25,703 $15,000
Q3 2019 Nov 14, 2019	SELL	$1.32 - $2.63 $528 - $1,052	-400 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.91 - $7.68 $9,797 - $82,682	-10,766 Reduced 96.42%	400 $0
Q1 2019 May 15, 2019	BUY	$4.26 - $10.56 $47,567 - $117,912	11,166 New	11,166 $82,000

31.5K

Ticker OTLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,144,992
Market Cap $1.21B
Description
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.